Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective Date 2nd September 2024
Solactive China Healthcare Disruption Index:
In the ordinary adjustment, the following composition will be implemented effective open 2nd September 2024:
| HUTCHMED CHINA LTD |
0.3625 % |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD |
8.0 % |
| GRAND PHARMACEUTICAL GROUP LTD |
0.2331 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD |
0.2513 % |
| GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD |
0.5 % |
| CSPC PHARMACEUTICAL GROUP LTD |
8.0 % |
| SINOPHARM GROUP CO LTD |
0.3785 % |
| SINO BIOPHARMACEUTICAL LTD ORD |
8.0 % |
| LIVZON PHARMACEUTICAL GROUP INC |
7.3804 % |
| GENSCRIPT BIOTECH CORP |
6.1848 % |
| INNOVENT BIOLOGICS INC |
8.0 % |
| SIMCERE PHARMACEUTICAL GROUP |
0.2008 % |
| LEPU BIOPHARMA CO LTD-H |
0.0706 % |
| KEYMED BIOSCIENCES INC |
0.1269 % |
| LUYE PHARMA GROUP LTD |
0.156 % |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD |
8.0 % |
| SHANGHAI MICROPORT MEDBOT GR |
1.4348 % |
| WUXI BIOLOGICS CAYMAN INC |
8.0 % |
| WUXI APPTEC CO LTD |
8.0 % |
| SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H |
0.5 % |
| SHANGHAI HENLIUS BIOTECH INC |
0.0536 % |
| CHINA RESOURCES PHARMACEUTICAL |
8.0 % |
| HANGZHOU TIGERMED CONSULTI-H |
0.5 % |
| HANSOH PHARMACEUTICAL GROUP CO |
8.0 % |
| PHARMARON BEIJING CO LTD-H |
0.4987 % |
| JD HEALTH INTERNATIONAL INC |
0.5 % |
| SKB BIO-B ORD H |
0.2988 % |
| ZAI LAB LTD |
0.1819 % |
| AKESO INC |
8.0 % |
| REMEGEN CO LTD-H |
0.1874 % |
